DG
BMY icon

DMC Group’s Bristol-Myers Squibb BMY Stock Holding History

DMC Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,597
Closed -$358K – 121
2024
Q1 		$358K Sell
6,597
-237
-3% -$12.1K 0.31% 94
2023
Q4 		$351K Sell
6,834
-2,830
-29% -$149K 0.33% 94
2023
Q3 		$561K Sell
9,664
-466
-5% -$28.6K 0.53% 56
2023
Q2 		$648K Sell
10,130
-340
-3% -$22.8K 0.65% 52
2023
Q1 		$730K Hold
10,470
– – 0.74% 45
2022
Q4 		$757K Sell
10,470
-435
-4% -$32.8K 0.85% 37
2022
Q3 		$769K Sell
10,905
-949
-8% -$68.8K 0.93% 27
2022
Q2 		$912K Sell
11,854
-49
-0.4% -$3.73K 1.08% 23
2022
Q1 		$902K Sell
11,903
-3,198
-21% -$215K 1.01% 25
2021
Q4 		$964K Buy
+15,101
New +$886K 0.83% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DMC Group's BMY Position: Q2 2024 in Review

DMC Group sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,597 shares — an estimated $358K sold.

DMC Group first reported a position in BMY in Q4 2021 and held it in 10 quarters. The position peaked at $964K in Q4 2021. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • DMC Group reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • DMC Group sold 6,597 Bristol-Myers Squibb shares in Q2 2024, an estimated $358K.
  • DMC Group first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 10 quarters.
  • DMC Group's Bristol-Myers Squibb position peaked at $964K in Q4 2021.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on DMC Group's 13F filing for Q2 2024, filed 16 Jul 2024.